Followers | 17 |
Posts | 1972 |
Boards Moderated | 1 |
Alias Born | 09/27/2020 |
![](https://investorshub.advfn.com/uicon/760444.png?cb=1664148451)
Thursday, December 14, 2023 1:06:05 AM
Tollovid target site for 3CL protease inhibition is the site nature targets. Pfizer's Paxlovid targets a different site on the protein, which Dr. Arad has previously stated is likely more susceptible to viral mutations rendering it less effective. Paxlovid is based on her earlier research, while Tollovid is based on her latest research. I know I'm using the better product and thankful that Dr. Arad and Todos has made it available to me.
![](http://investorshub.advfn.com/uimage/uploads/2023/12/14/kmfzyA1.png)
![](http://investorshub.advfn.com/uimage/uploads/2023/12/14/wjppdA2.png)
![](http://investorshub.advfn.com/uimage/uploads/2023/12/14/tetafA3.png)
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • ELMGF • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM